Boston Scientific Is A Good Earnings Story – Cramer’s Lightning Round (6/13/18)

Seeking Alpha

Stocks discussed on the Lightning Round segment of Jim Cramer’s Mad Money Program, Wednesday, June 13.

Bullish Calls

Xylem (NYSE:XYL): “We like anything water related.” It has come down a little bit but it’s a buy.

Kemet (NYSE:KEM): It’s an inexpensive semiconductor stock that is a little speculative. It’s worth buying.

Iovance Biotherapeutics (NASDAQ:IOVA): It’s a speculative oncology company because they tend to get takeover bids.

Boston Scientific (NYSE:BSX): The company’s takeover bid did not materialize but it’s still a good earnings story.

Magellan Midstream Partners (NYSE:MMP): Cramer admitted he was wrong to sell it for his charitable trust. “CEO Michael Mears came on this show when the stock was really, really low and said, ‘Buy it’. He was right,” said Cramer.

Bearish Calls

Karyopharm Therapeutics (NASDAQ:KPTI): It’s a speculative situation for a billion dollar company.

New Residential Investment (NYSE:NRZ): These high yielders have mortgages and it is tough to find out if they are good or bad. Don’t buy.

Casella Waste Systems (NASDAQ:CWST): Waste Management (NYSE:WM) is bigger and better.


Jim Cramer’s Action Alerts PLUS: Check out Cramer’s multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer’s Picks by email – it’s free and takes only a few seconds to sign up

Leave a Reply